Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. (2020)

First Author: Wang Y
Attributed to:  COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31022-9

PubMed Identifier: 32423584

Publication URI: http://europepmc.org/abstract/MED/32423584

Type: Journal Article/Review

Volume: 395

Parent Publication: Lancet (London, England)

Issue: 10236

ISSN: 0140-6736